BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35652641)

  • 1. Risk Factors for the Development of Colistin Resistance during Colistin Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections.
    Huang PH; Chen WY; Chou SH; Wang FD; Lin YT
    Microbiol Spectr; 2022 Jun; 10(3):e0038122. PubMed ID: 35652641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and mechanisms of in vivo emergence of colistin resistance in carbapenem-resistant Klebsiella pneumoniae.
    Huang PH; Cheng YH; Chen WY; Juan CH; Chou SH; Wang JT; Chuang C; Wang FD; Lin YT
    Int J Antimicrob Agents; 2021 Jun; 57(6):106342. PubMed ID: 33864932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality.
    Rojas LJ; Salim M; Cober E; Richter SS; Perez F; Salata RA; Kalayjian RC; Watkins RR; Marshall S; Rudin SD; Domitrovic TN; Hujer AM; Hujer KM; Doi Y; Kaye KS; Evans S; Fowler VG; Bonomo RA; van Duin D;
    Clin Infect Dis; 2017 Mar; 64(6):711-718. PubMed ID: 27940944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of tigecycline- and colistin-resistant CRKP (carbapenem-resistant Klebsiella pneumoniae) in vivo and its persistence in the GI tract.
    Zhang R; Dong N; Huang Y; Zhou H; Xie M; Chan EW; Hu Y; Cai J; Chen S
    Emerg Microbes Infect; 2018 Jul; 7(1):127. PubMed ID: 29985412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance evolution of hypervirulent carbapenem-resistant
    Jin X; Chen Q; Shen F; Jiang Y; Wu X; Hua X; Fu Y; Yu Y
    Emerg Microbes Infect; 2021 Dec; 10(1):1129-1136. PubMed ID: 34074225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A challenging case of carbapenem resistant Klebsiella pneumoniae-related pyogenic liver abscess with capsular polysaccharide hyperproduction: a case report.
    Sohrabi M; Pirbonyeh N; Alizade Naini M; Rasekhi A; Ayoub A; Hashemizadeh Z; Shahcheraghi F
    BMC Infect Dis; 2024 Apr; 24(1):433. PubMed ID: 38654215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcome of non-carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae infections: a multicenter study in Taiwan.
    Su CF; Chuang C; Lin YT; Chan YJ; Lin JC; Lu PL; Huang CT; Wang JT; Chuang YC; Siu LK; Fung CP
    Eur J Clin Microbiol Infect Dis; 2018 Apr; 37(4):651-659. PubMed ID: 29238934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colistin resistance increases 28-day mortality in bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae.
    Balkan II; Alkan M; Aygün G; Kuşkucu M; Ankaralı H; Karagöz A; Şen S; Arsu HY; Biçer M; Kaya SY; Karaali R; Mete B; Saltoğlu N; Tabak F
    Eur J Clin Microbiol Infect Dis; 2021 Oct; 40(10):2161-2170. PubMed ID: 33963928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: Risk factors, mortality, and antimicrobial susceptibility, 2017-2019.
    Hsu JY; Chuang YC; Wang JT; Chen YC; Hsieh SM
    J Formos Med Assoc; 2021 Nov; 120(11):1994-2002. PubMed ID: 33962811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Colistin resistance in carbapenem-resistant Klebsiella pneumoniae isolates from a pediatric hospital from Corrientes, Argentina].
    Pellegrini JL; Aguirre C; Soto SM; Lovera LMR; Lösch LS; Conza JAD; Merino LA
    Rev Chilena Infectol; 2022 Apr; 39(2):109-116. PubMed ID: 35856982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae.
    Tian Y; Zhang Q; Wen L; Chen J
    Microbiol Spectr; 2021 Oct; 9(2):e0015221. PubMed ID: 34704782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical carbapenem-resistant
    Shahid M; Ahmad N; Saeed NK; Shadab M; Joji RM; Al-Mahmeed A; Bindayna KM; Tabbara KS; Dar FK
    Front Cell Infect Microbiol; 2022; 12():1033305. PubMed ID: 36304935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of imipenem/relebactam and ceftazidime/avibactam against carbapenem-resistant Klebsiella pneumoniae from blood cultures in a University hospital in Serbia.
    Zornic S; Petrovic I; Lukovic B
    Acta Microbiol Immunol Hung; 2023 Sep; 70(3):187-192. PubMed ID: 37535440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of a Fatal ST11-KL64 Tigecycline-Resistant Hypervirulent Klebsiella pneumoniae Clone Cocarrying
    Huang J; Yi M; Yuan Y; Xia P; Yang B; Liao J; Dang Z; Luo S; Xia Y
    Microbiol Spectr; 2022 Dec; 10(6):e0253922. PubMed ID: 36205391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of NDM-1 and OXA-48 carbapenemase genes among Klebsiella pneumoniae isolates in central Iran.
    Abbasi E; Ghaznavi-Rad E
    BMC Microbiol; 2023 Apr; 23(1):98. PubMed ID: 37038144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients.
    Mohammadi M; Saffari M; Siadat SD; Hejazi SH; Shayestehpour M; Motallebi M; Eidi M
    Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):18. PubMed ID: 36829156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of colistin resistance and other predictors on fatality among patients with bloodstream infections due to Klebsiella pneumoniae in an OXA-48 dominant region.
    Menekşe Ş; Çağ Y; Işık ME; Şahin S; Hacıseyitoğlu D; Can F; Ergonul O
    Int J Infect Dis; 2019 Sep; 86():208-211. PubMed ID: 31402295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for acquisition of colistin-resistant
    Baron SA; Cassir N; Hamel M; Hadjadj L; Saidani N; Dubourg G; Rolain JM
    Euro Surveill; 2021 May; 26(21):. PubMed ID: 34047270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole genome sequencing for the molecular characterization of carbapenem-resistant Klebsiella pneumoniae strains isolated at the Italian ASST Fatebenefratelli Sacco Hospital, 2012-2014.
    Rimoldi SG; Gentile B; Pagani C; Di Gregorio A; Anselmo A; Palozzi AM; Fortunato A; Pittiglio V; Ridolfo AL; Gismondo MR; Rizzardini G; Lista F
    BMC Infect Dis; 2017 Oct; 17(1):666. PubMed ID: 29017452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Epidemiology and Drug Resistance Pattern of Carbapenem-Resistant Klebsiella pneumoniae Isolates from Iran.
    Jafari Z; Harati AA; Haeili M; Kardan-Yamchi J; Jafari S; Jabalameli F; Meysamie A; Abdollahi A; Feizabadi MM
    Microb Drug Resist; 2019 Apr; 25(3):336-343. PubMed ID: 30351186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.